Parkman Healthcare Partners LLC Vertex Pharmaceuticals Inc Transaction History

Parkman Healthcare Partners LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 12, 2021	SELL	$207.01 - $276.09 $4.66 Million - $6.21 Million	-22,501 Closed	0 $0
Q3 2020 Nov 13, 2020	BUY	$255.65 - $303.1 $639,380 - $758,053	2,501 Added 12.51%	22,501 $6.12 Million
Q2 2020 Aug 13, 2020	SELL	$225.48 - $295.8 $5.15 Million - $6.76 Million	-22,842 Reduced 53.32%	20,000 $5.81 Million
Q1 2020 May 15, 2020	SELL	$199.77 - $247.81 $466,263 - $578,388	-2,334 Reduced 5.17%	42,842 $10.2 Million
Q4 2019 Feb 13, 2020	BUY	$166.71 - $223.91 $7.53 Million - $10.1 Million	45,176 New	45,176 $9.89 Million

1,724

222M

1.58M

1.36M

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $119B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

Get notified when there are updates to the investment portfolio of Parkman Healthcare Partners LLC, based on Form 13F filings with the SEC.

Stay updated on Parkman Healthcare Partners LLC with notifications on news.